Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Becton Dickinson/Luther Medical

This article was originally published in The Gray Sheet

Executive Summary

Becton Dickinson increases to $4.70 from $4.62-per-share its October bid for each of Luther Medical Products' roughly 3.2 mil. outstanding common stock shares, Luther reports Dec. 8. Terms of the revised deal also call for Luther to grant BD a six-month option for an 18-month license to a Luther needle stick protection patent. The patent relates to technology, for which FDA market clearance was simultaneously announced, that "has the capability of providing a needle stick protection feature to approximately half of the Luther Medical product range," Luther says. In the event that BD fails to consummate the merger, BD would pay Luther $325,000 cash in consideration of the patent option, followed by an additional $200,000 if BD decides to exercise that option
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011054

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel